Rocket Lab’s first quarter results drew a negative market reaction, with management pointing to both operational progress and ongoing investment as central themes. CEO Peter Beck emphasized strong demand for Electron and HASTE launches, as well as advancements in the Neutron program. He noted, “We continue to launch and book more and more Electron missions proving we hold the keys to space with regular launch access.” While revenue growth was driven primarily by the Space Systems segment, the quarter’s margin profile was pressured by lower average selling prices in key launch contracts and continued development investments, particularly in Neutron.
Is now the time to buy RKLB? Find out in our full research report (it’s free).
Rocket Lab (RKLB) Q1 CY2025 Highlights:
- Revenue: $122.6 million vs analyst estimates of $121.6 million (32.1% year-on-year growth, 0.8% beat)
- Adjusted EPS: -$0.07 vs analyst estimates of -$0.09 (17.9% beat)
- Adjusted EBITDA: -$29.96 million vs analyst estimates of -$33.63 million (-24.4% margin, 10.9% beat)
- Revenue Guidance for Q2 CY2025 is $135 million at the midpoint, below analyst estimates of $137.3 million
- EBITDA guidance for Q2 CY2025 is $29 million at the midpoint, above analyst estimates of -$20.45 million
- Operating Margin: -48.3%, down from -46.4% in the same quarter last year
- Market Capitalization: $16.45 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions.
Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated.
Here is what has caught our attention.
Our Top 5 Analyst Questions Rocket Lab’s Q1 Earnings Call
- Edison Yu (Deutsche Bank) inquired about the Mynaric acquisition challenges and potential for margin improvement. CEO Peter Beck cited production as Mynaric’s main issue, emphasizing Rocket Lab’s strength in scaling manufacturing, while CFO Adam Spice anticipated blended margins in line with existing components.
- Gautam Khanna (TD Securities) asked about launch margin variability and free cash flow trajectory. Beck explained that cadence and ASP drive launch margins, while Spice noted elevated negative cash flow will persist until Neutron’s first launch due to ongoing investments.
- Ryan Koontz (Needham) sought details on the new modular solar array product and European market entry. Beck highlighted customer demand for rapid deployment and described Europe as a significant opportunity, enabled by Mynaric’s local footprint.
- Andre Madrid (BTIG) questioned backlog mix and the status of margin improvements in the SolAero business. Spice confirmed SolAero had reached target profitability and explained that revenue mix will remain volatile, with large constellation wins or Neutron contracts able to shift the balance quickly.
- Jason Gursky (Citi) explored the strategic rationale for the Mynaric deal and Rocket Lab’s approach to government versus commercial constellation projects. Beck confirmed the dual purpose of securing merchant business and supporting future internal constellation ambitions, with a focus on scaling vertically integrated solutions.
Catalysts in Upcoming Quarters
In coming quarters, our analysts will monitor (1) the pace and success of Neutron’s first launch and subsequent government contract wins, (2) the integration and performance of Mynaric’s laser communications business in Europe, and (3) progress in expanding launch cadence and average selling prices. Execution on large constellation contracts, backlog growth, and stabilization of free cash flow will also be key markers of Rocket Lab’s ability to transition its business mix and achieve targeted profitability.
Rocket Lab currently trades at $36.59, up from $23.13 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).
The Best Stocks for High-Quality Investors
Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.